MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 13 - per page Next page
Order by
Diclofenac potassium immediate release tablets 25 and 50 mg
25 and 50 mg diclofenac K film coated immediate release tablets More
Cellophil(TM) Biomedical Polymer - New and superior biomedical polymers for a new standard in the medical device industry.
Cellophil (TM) is particularly designed for optical lenses, drug delivery and also may be used as additive for food and cosmetics or as fiber for fabrics. More
Transdermal Diclofenac
Diclofenac transdermal gel for the treatment of inflammatory and painful conditions More
Diclofenac Sodium 25 mg. immediate release tablets
25mg dosage strenght for the OTC market in film coated tablets More
APR Fastest for Migraine
The First Line of Therapy in Severe Migraine Attacks More
140mg Diclofenac Sodium Matrix Patch
Locally applied and locally acting NSAID Matrix Patch containing 140 mg Diclofenac Sodium More
Diclofenac Sodium 25 mg. immediate release powder in Sachet
25mg dosage strenght for the OTC market More
Retinoid Acid Receptor Antagonists in Bone and Cartilage Repair
Identification and use of RAR antagonists to induce bone and cartilage formation More
Diclofenac potassium oral drops at 5%
The first pure, immediate release (Tmax in 13,68 min), completely palatable and free from aftertaste diclofenac potassium formulation in drops at 5% available on the market More
Novel Peptide Therapeutics for Bone Regeneration
Suite of proprietary collagen-binding peptides derived from bone sialoprotein (BSP) that are effective in promoting bone repair and regeneration. More
Displaying 1..10 of 13 - per page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us